Timetable icon Self-scheduling is currently available for select locations!

OCLI Blog

November 17, 2020
November 17, 2020

OCLI Partners with Bionic Sight in Clinical Trial of New Treatment for Blindness

State-of-the-art eye care practice to assess Bionic Sight’s optogenetic therapy for blindness caused by retinitis pigmentosa NEW YORK, N.Y.—November 17, 2020—OCLI, one of the leading ophthalmology practices in the United States, today announced that it’s starting a clinical trial in partnership with Bionic Sight, the developer of BS01, a new investigational therapy for patients with…

October 7, 2020
October 7, 2020

Visus Therapeutics Launches and Announces Clinical Development Program for Novel Presbyopia Eye Drop

Patent Assets Acquired from Acclaimed Ophthalmologist and Innovator Herb Kaufman, M.D., to Progress to Phase II Studies Eric Donnenfeld, M.D., Appointed Leader of Clinical Advisory Board, Bringing World-Class Ophthalmology Expertise as Company Moves Into Clinical Development Visus Therapeutics Inc. today (September 28, 2020) announced its launch and clinical development program for a novel eye drop…

September 28, 2020
September 28, 2020

OCLI Welcomes Board-Certified Ophthalmologist Lewis Weinstein, MD

NEW YORK, N.Y.—September 28, 2020—OCLI, a state-of-the-art multi-practice ophthalmology group in Long Island, today announced the addition of Lewis Weinstein, MD, a highly experienced, board-certified comprehensive ophthalmologist. On October 5, 2020, he will begin seeing patients at OCLI’s Huntington Park Avenue office, located at 755 Park Ave, Suite 100. Dr. Weinstein earned his medical degree…

Services offered at OCLI

Our world-class team of professionals at OCLI can help you with the latest treatment options for you.

Schedule an appointment

Are you a new patient? *